Company News

Video | Investor Briefing | PHASE Scientific Agreement

16 Jul 2025

Lumos held an investor briefing outlining the transformational US$317 million distribution agreement with PHASE Scientific.

Share in X

Keep reading

More news & media.

A few more pieces along the same thread. See the full index for everything.

21 Sep 2026 1 min read

MST Access has published a research report on Lumos Diagnostics Limited.

LD Lumos Diagnostics Communications Written with AI assistance

16 Sep 2026 2 min read

Lumos Diagnostics has announced further progress in the U.S. commercialisation of FebriDx® across its priority top-100 urgent care target list.

LD Lumos Diagnostics Communications Written with AI assistance

12 Jun 2026 1 min read

Lumos CEO Doug Ward, Lumos Chief Commercial Officer Paul Kase, Lumos Director of U.S. Sales

LD Lumos Diagnostics Communications Written with AI assistance